These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30257714)

  • 1. Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma.
    Jun S; Park JG; Seo Y
    Cancer Imaging; 2018 Sep; 18(1):35. PubMed ID: 30257714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. A study in patients with papillary thyroid carcinoma.
    Jun S; Kim H; Nam HY
    Nuklearmedizin; 2015; 54(6):272-85. PubMed ID: 26429587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
    Ma C; Li D; Yin Y; Cao J
    Nucl Med Commun; 2015 Dec; 36(12):1181-6. PubMed ID: 26367213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
    Xu W; Yu S; Ma Y; Liu C; Xin J
    Nucl Med Commun; 2017 Mar; 38(3):259-265. PubMed ID: 28118260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More accurate than MRI measurement of tumor size in breast cancer by using the peri-tumoral halo uptake layer method of the
    Park SH; Seo M; Choi HJ; Bae K; Bang M; Jun S
    Hell J Nucl Med; 2018; 21(2):108-114. PubMed ID: 30006644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
    Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
    Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
    Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of sequential (18)F-FDG PET/CT scans for concurrent chemoradiotherapy of non-surgical squamous cell esophageal carcinoma.
    Li Y; Lin Q; Wang L; Sun L; Dai M; Luo Z; Zheng H; Zhao L; Wu H
    J BUON; 2014; 19(2):517-23. PubMed ID: 24965415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
    Liu CJ; Cheng JC; Lee JM; Cheng MF; Tzen KY; Yen RF
    Clin Nucl Med; 2015 May; 40(5):384-9. PubMed ID: 25674870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
    J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid segmentation using perithyroidal halo layer on
    Seo Y; Lee WW; Kang G; Shong MH; Joung KH; Kim SM; Jun S
    Hell J Nucl Med; 2023; 26(2):84-93. PubMed ID: 37527043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.
    Zhang G; Han D; Ma C; Lu J; Sun T; Liu T; Zhu J; Zhou J; Yin Y
    Radiat Oncol; 2015 Jan; 10():11. PubMed ID: 25572431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
    Zhong X; Yu J; Zhang B; Mu D; Zhang W; Li D; Han A; Song P; Li H; Yang G; Kong FM; Fu Z
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):136-41. PubMed ID: 18538492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation.
    Mamede M; El Fakhri G; Abreu-e-Lima P; Gandler W; Nosé V; Gerbaudo VH
    Ann Nucl Med; 2007 Dec; 21(10):553-62. PubMed ID: 18092131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
    J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.
    Hamai Y; Hihara J; Emi M; Furukawa T; Yamakita I; Kurokawa T; Okada M
    Ann Thorac Surg; 2016 Oct; 102(4):1132-9. PubMed ID: 27319990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.
    Tanabe S; Naomoto Y; Shirakawa Y; Fujiwara Y; Sakurama K; Noma K; Takaoka M; Yamatsuji T; Hiraki T; Okumura Y; Mitani M; Kaji M; Kanazawa S; Fujiwara T
    Clin Nucl Med; 2011 Oct; 36(10):854-9. PubMed ID: 21892033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma.
    Makino T; Doki Y; Miyata H; Yasuda T; Yamasaki M; Fujiwara Y; Takiguchi S; Higuchi I; Hatazawa J; Monden M
    Surgery; 2008 Nov; 144(5):793-802. PubMed ID: 19081023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.